Aflibercept formulations and uses thereof
Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
11.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration. |
---|---|
Bibliography: | Application Number: US202117492649 |